Milestone Scientific Inc. (MLSS) stock
MLSSNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3015% below fair value
$0.29−0.02 (-6.36%)
Close on Nov 12, 2026Market cap $25.73MP/E –Yield –
Milestone Scientific profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Milestone Scientific's profit margin for the twelve months ending Sep 30, 2026 was -38.3%. For fiscal 2025 it was -63.8%, against -54.6% the year before. The highest annual figure on record is 14.6% in fiscal 2013.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -63.8% | −9.1 |
| FY2024 | Dec 31, 2024 | -54.6% | +15.9 |
| FY2023 | Dec 31, 2023 | -70.5% | +28.4 |
| FY2022 | Dec 31, 2022 | -98.9% | −32.7 |
| FY2021 | Dec 31, 2021 | -66.2% | +68.8 |
| FY2020 | Dec 31, 2020 | -134.9% | −45.1 |
| FY2019 | Dec 31, 2019 | -89.8% | −12.6 |
| FY2018 | Dec 31, 2018 | -77.2% | −31.3 |
| FY2017 | Dec 31, 2017 | -46.0% | +10.8 |
| FY2016 | Dec 31, 2016 | -56.7% | +0.9 |
| FY2015 | Dec 31, 2015 | -57.6% | −41.1 |
| FY2014 | Dec 31, 2014 | -16.5% | −31.1 |
| FY2013 | Dec 31, 2013 | 14.6% | +24.7 |
| FY2012 | Dec 31, 2012 | -10.1% | +7.6 |
| FY2011 | Dec 31, 2011 | -17.7% | −11.4 |
| FY2010 | Dec 31, 2010 | -6.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -33.7% | +15.2 |
| Q2 FY2026 | Jun 30, 2026 | -33.8% | +30.0 |
| Q1 FY2026 | Mar 31, 2026 | -35.1% | +54.2 |
| Q4 FY2025 | Dec 31, 2025 | -53.0% | +48.1 |
| Q3 FY2025 | Sep 30, 2025 | -48.9% | +9.2 |
| Q2 FY2025 | Jun 30, 2025 | -63.8% | −75.9 |
| Q1 FY2025 | Mar 31, 2025 | -89.3% | −25.3 |
| Q4 FY2024 | Dec 31, 2024 | -101.1% | −15.3 |
| Q3 FY2024 | Sep 30, 2024 | -58.1% | +13.1 |
| Q2 FY2024 | Jun 30, 2024 | 12.1% | +88.2 |
| Q1 FY2024 | Mar 31, 2024 | -64.1% | −13.7 |
| Q4 FY2023 | Dec 31, 2023 | -85.8% | +2.3 |
| Q3 FY2023 | Sep 30, 2023 | -71.2% | +17.8 |
| Q2 FY2023 | Jun 30, 2023 | -76.2% | +97.2 |
| Q1 FY2023 | Mar 31, 2023 | -50.3% | +20.1 |
| Q4 FY2022 | Dec 31, 2022 | -88.1% | −48.7 |
| Q3 FY2022 | Sep 30, 2022 | -89.0% | +7.9 |
| Q2 FY2022 | Jun 30, 2022 | -173.4% | −62.9 |
| Q1 FY2022 | Mar 31, 2022 | -70.4% | −37.1 |
| Q4 FY2021 | Dec 31, 2021 | -39.4% | +9.4 |
| Q3 FY2021 | Sep 30, 2021 | -96.9% | +22.7 |
| Q2 FY2021 | Jun 30, 2021 | -110.5% | +1778.0 |
| Q1 FY2021 | Mar 31, 2021 | -33.3% | +55.1 |
| Q4 FY2020 | Dec 31, 2020 | -48.8% | +75.6 |
| Q3 FY2020 | Sep 30, 2020 | -119.7% | +29.7 |
| Q2 FY2020 | Jun 30, 2020 | -1888.5% | −1842.3 |
| Q1 FY2020 | Mar 31, 2020 | -88.3% | −47.5 |
| Q4 FY2019 | Dec 31, 2019 | -124.4% | −129.2 |
| Q3 FY2019 | Sep 30, 2019 | -149.3% | +121.5 |
| Q2 FY2019 | Jun 30, 2019 | -46.1% | +9.2 |
| Q1 FY2019 | Mar 31, 2019 | -40.9% | +62.9 |
| Q4 FY2018 | Dec 31, 2018 | 4.8% | +85.6 |
| Q3 FY2018 | Sep 30, 2018 | -270.8% | −221.3 |
| Q2 FY2018 | Jun 30, 2018 | -55.3% | +3.3 |
| Q1 FY2018 | Mar 31, 2018 | -103.8% | −90.1 |
| Q4 FY2017 | Dec 31, 2017 | -80.8% | +34.5 |
| Q3 FY2017 | Sep 30, 2017 | -49.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -58.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -13.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -115.3% | – |
See a number that looks wrong?